在类风湿性关节炎中使用勒弗卢诺米德治疗后的肺结节:一个病例报告
Mahdiye Abiyarghamsari1,2, Arman Ahmadzadeh3
1Department of Clinical Pharmacy, School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran.
Clinical case reports
|December 31, 2024
概括
对类风湿性关节炎的leflunomide治疗可能会导致罕见的肺部并发症. 停止服用该药物导致一个患者的肺结核解决,突出显示需要监测.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性关节炎 (RA) 是一种全身性自身免疫性疾病.
- 关节炎可以表现为关节和关节外的表现.
- 肺部并发症在RA患者中很少发生,但很严重.
研究的目的:
- 报告一种罕见的风湿性关节炎患者的莱夫卢诺米德二次性肺毒性病例.
- 强调认识到药物诱导的肺部疾病的重要性.
- 突出诊断的挑战和管理这些并发症.
主要方法:
- 一个65岁的男性长期患有RA的病例报告.
- 评估包括排除传染病,瘤和自身免疫病因.
- 诊断过程包括支气管镜检查和活检.
主要成果:
- 患者在长时间的莱夫卢诺米德治疗后发展出多个腔腔肺结节.
- 支气管镜检查和活检揭示了急性性炎症过程与中心亡.
- 停用莱夫卢诺米德导致肺结节的完全消失.
结论:
- 莱弗卢诺米德可以诱导风湿性关节炎患者的肺部并发症.
- 迅速识别和管理药物诱导的肺毒性至关重要.
- 警潜在的莱夫卢诺米德相关的肺部问题在RA管理中至关重要.
相关概念视频
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Pneumonia III: Complications and Assessment
1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumothorax-II
1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.7K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30


